Vaccinology: Horizons Across Disease, Demography and Technology
June 4-7, 2025 | Marriott Marquis Washington, DC, Washington, DC, United States
Scientific Organizers:
Rino Rappuoli, Kanta Subbarao, Laurence Zitvogel and Firdausi Qadri
In Person
On Demand
June 4-7, 2025 | Marriott Marquis Washington, DC, Washington, DC, United States
Scientific Organizers:
Rino Rappuoli, Kanta Subbarao, Laurence Zitvogel and Firdausi Qadri
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Fundraising
Merchandise Options
Registration Options
Booking Function
Wednesday, June 4, 2025
Registration
11:00–4:30 PM
Joint Plenary Session: Grand Challenges Annual Meeting & Keystone Symposia
2:30–4:30 PM
Thursday, June 5, 2025
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Anthony S. Fauci, Georgetown University School of Medicine and McCourt School of Public Policy
Talk Title to be Announced
Talk Title to be Announced
Learning the Molecular Immunology of mRNA Vaccines
9:00–11:15 AM
Bali Pulendran, Stanford University School of Medicine
Comparative Responses to mRNA and Adjuvanted Vaccines
Comparative Responses to mRNA and Adjuvanted Vaccines
Ali H. Ellebedy, Washington University School of Medicine
B Cell Responses to mRNA Vaccination/Induction of New Epitopes
B Cell Responses to mRNA Vaccination/Induction of New Epitopes
Rita Carsetti, Bambino Gesù Children Hospital
Early Immune Responses to Vaccination
Early Immune Responses to Vaccination
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
On Own for Lunch
11:15–5:00 PM
Poster Setup
11:15–1:00 PM
Poster Viewing
1:00–10:00 PM
Workshop 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Vaccines, Emerging Reality in Cancer Therapy
5:00–7:00 PM
Catherine J. Wu, Dana-Farber Cancer Institute
DNA-Based Cancer Vaccines
DNA-Based Cancer Vaccines
Ira Mellman, Genentech, Inc.
Combining Checkpoints Inhibitor Immunotherapy and Personalized Vaccines
Combining Checkpoints Inhibitor Immunotherapy and Personalized Vaccines
Laura K. Mackay, University of Melbourne
Talk Title to be Announced
Talk Title to be Announced
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Friday, June 6, 2025
Breakfast
7:00–8:00 AM
Preparing for New Pandemics and Emerging Infections
8:00–11:00 AM
Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza
WHO Strategy, One Health Considerations, Equity
WHO Strategy, One Health Considerations, Equity
Penny L. Moore, University of the Witwatersrand and National Institute for Communicable Diseases
Views from the African Continent
Views from the African Continent
Cristina Cassetti, NIAID, National Institutes of Health
Prototype Vaccines
Prototype Vaccines
Rino Rappuoli, Fondazione Biotecnopolo di Siena
An Institute for Pandemic Preparedness
An Institute for Pandemic Preparedness
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Health Equity Forum
11:00–12:15 PM
Poster Viewing
1:00–10:00 PM
Panel Discussion: Pandemic and Antimicrobial Resistance Preparedness
1:00–2:45 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Understanding Mechanistic Immunology to Drive Vaccine Design
5:00–7:00 PM
Michel C. Nussenzweig, HHMI/Rockefeller University
Germinal Center Selection
Germinal Center Selection
Emanuele Andreano, Fondazione Toscana Life Sciences
B Cell Responses
B Cell Responses
Federica Sallusto, Università della Svizzera Italiana & ETH Zurich
T Cell Responses
T Cell Responses
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Saturday, June 7, 2025
Breakfast
7:00–8:00 AM
Designing and Evaluating New Vaccines
8:00–11:00 AM
Jason S. McLellan, University of Texas at Austin
Structure Based Design
Structure Based Design
Wolfgang W. Leitner, National Institute of Allergy and Infectious Diseases, NIH, DHHS
NIH Adjuvant Program
NIH Adjuvant Program
Galit Alter, Moderna, Inc.
Mechanistic and Non Mechanistic Correlates of Protection
Mechanistic and Non Mechanistic Correlates of Protection
Florian Krammer, Icahn School of Medicine at Mount Sinai
Development of Broadly Protective Vaccines to Antigenically Variable Viruses
Development of Broadly Protective Vaccines to Antigenically Variable Viruses
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Workshop 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Exploiting Tissue Specific Protection to Prevention and Cure
5:00–6:45 PM
Gabriel D. Victora †, Rockefeller University
Talk Title to be Announced
Talk Title to be Announced
Laurence Zitvogel, Institut Gustave Roussy
Gut Microbiota Impacts the Immunogenicity of Vaccines
Gut Microbiota Impacts the Immunogenicity of Vaccines
Christopher Chiu, Imperial College London
Clinical Trials for Intranasal and Aerosol SARS-CoV-2 Vaccine Development
Clinical Trials for Intranasal and Aerosol SARS-CoV-2 Vaccine Development
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Sunday, June 8, 2025
Departure
12:00–11:59 PM
Subscribe for Updates